|
SLC16A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.04405414605935E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.4698004165773E-10 |
| Normal-vs-Stage2 |
7.400100E-04 |
| Normal-vs-Stage3 |
4.047200E-04 |
| Normal-vs-Stage4 |
1.216020E-03 |
| Stage1-vs-Stage2 |
2.858000E-01 |
| Stage1-vs-Stage3 |
8.597800E-01 |
| Stage1-vs-Stage4 |
6.581200E-01 |
| Stage2-vs-Stage3 |
2.703200E-01 |
| Stage2-vs-Stage4 |
5.555200E-01 |
| Stage3-vs-Stage4 |
6.392600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.858400100474E-10 |
| Normal-vs-AfricanAmerican |
1.428600E-01 |
| Normal-vs-Asian |
1.434530E-04 |
| Caucasian-vs-AfricanAmerican |
3.113800E-01 |
| Caucasian-vs-Asian |
8.881400E-01 |
| AfricanAmerican-vs-Asian |
2.927400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.05400000000233E-06 |
| Normal-vs-Female |
1.78780323878414E-11 |
| Male-vs-Female |
3.872200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.96889998643957E-09 |
| Normal-vs-Age(41-60Yrs) |
2.0665999999947E-05 |
| Normal-vs-Age(61-80Yrs) |
2.09149999998992E-05 |
| Normal-vs-Age(81-100Yrs) |
1.128620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.127700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.950800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.547000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.128300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.156000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.092600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.956800E-01 |
| Classical-VS-Follicular |
8.017800E-01 |
| Classical-VS-Other |
4.134600E-01 |
| Classical-VS-Normal |
3.31590310764796E-12 |
| Tall-VS-Follicular |
4.493600E-01 |
| Tall-VS-Other |
2.106000E-01 |
| Tall-VS-Normal |
2.010300E-02 |
| Follicular-VS-Other |
5.450200E-01 |
| Follicular-VS-Normal |
6.431400E-04 |
| Other-VS-Normal |
4.368400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97139999991158E-07 |
| Normal-vs-N1 |
3.956600E-03 |
| N0-vs-N1 |
8.397000E-01 |
|
|
